Järbe T U, Ostlund A, Hiltunen A J
Department of Psychology, University of Uppsala, Sweden.
Psychopharmacology (Berl). 1988;94(4):501-6. doi: 10.1007/BF00212845.
Two groups of gerbils were trained in a T-maze to discriminate between the vehicle condition (4 ml/kg) and either of the benzodiazepine (BDZ) agonists diazepam (DZP) and Ro 11-3128; administration (5.6 mg/kg) was IP 5 min prior to training onset. Once trained, novel doses and drugs were assessed in test sessions interposed between the regular training days. A dose-related generalization effect occurred with both compounds (range 0.1-5.6 mg/kg), the effect being similar at both the 5 and 15 min test intervals; the two intervals were evaluated after a single injection. The lack of generalization of Ro 11-3624 (range 5.6-56 mg/kg) indicates a stereoisomeric separation of BDZ agonist activity. Ro 5-4864 (range 17.5-56 mg/kg), an agent chemically/structurally related to DZP, did not produce DZP responding at either of the two test inverals; clear-cut convulsant activity occurred at the 15 min interval. The convulsant BDZ compound Ro 5-3663 (3 and 10 mg/kg) antagonized the DZP stimulus irrespective of whether Ro 5-3663 was given either prior to, simultaneously with, or shortly after the DZP injection.
将两组沙鼠置于T型迷宫中进行训练,以区分溶剂对照条件(4毫升/千克)与苯二氮䓬(BDZ)激动剂地西泮(DZP)和Ro 11 - 3128中的任意一种;在训练开始前5分钟腹腔注射给药(5.6毫克/千克)。一旦完成训练,就在常规训练日之间插入的测试环节中评估新的剂量和药物。两种化合物(剂量范围0.1 - 5.6毫克/千克)均出现了剂量相关的泛化效应,在5分钟和15分钟的测试间隔时效应相似;在单次注射后对这两个间隔进行了评估。Ro 11 - 3624(剂量范围5.6 - 56毫克/千克)未出现泛化现象,表明BDZ激动剂活性存在立体异构体分离。Ro 5 - 4864(剂量范围17.5 - 56毫克/千克)是一种在化学结构上与DZP相关的药物,在两个测试间隔中的任何一个时间点均未产生类似DZP的反应;在15分钟间隔时出现了明显的惊厥活性。惊厥性BDZ化合物Ro 5 - 3663(3毫克/千克和10毫克/千克)拮抗了DZP刺激,无论Ro 5 - 3663是在DZP注射之前、同时还是之后不久给药。